Forte Biosciences (FBRX) EBIT (2016 - 2026)
Forte Biosciences' EBIT came in at -$24.6 million for Q2 2026, compared with -$11.58 million a year earlier.
Powered by 
Analysis
Forte Biosciences (FBRX) EBIT (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Forte Biosciences reported EBIT of -$90 million; for FY2025, it came in at -$70.66 million.
- Going back by year, EBIT was -$36.6 million in FY2024, -$32.49 million in FY2023, -$13.9 million in FY2022 and -$21.49 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly EBIT since Q2 2020.
- Business Quant data shows FBRX's EBIT at -$22.44 million (Q1 2026), -$24.57 million (Q4 2025) and -$18.38 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Forte Biosciences | 1.58 Bn | 1.38 Bn | - | -24.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -24.60 Mn |
| Mar 31, 2026 | -22.44 Mn |
| Dec 31, 2025 | -24.57 Mn |
| Sep 30, 2025 | -18.38 Mn |
| Jun 30, 2025 | -11.58 Mn |
| Mar 31, 2025 | -16.12 Mn |
| Dec 31, 2024 | -7.35 Mn |
| Sep 30, 2024 | -8.63 Mn |
| Jun 30, 2024 | -12.82 Mn |
| Mar 31, 2024 | -7.80 Mn |
| Dec 31, 2023 | -6.38 Mn |
| Sep 30, 2023 | -10.22 Mn |
| Jun 30, 2023 | -9.03 Mn |
| Mar 31, 2023 | -6.86 Mn |
| Dec 31, 2022 | -4.94 Mn |
| Sep 30, 2022 | -3.42 Mn |
| Jun 30, 2022 | -3.02 Mn |
| Mar 31, 2022 | -2.51 Mn |
| Dec 31, 2021 | -3.30 Mn |
| Sep 30, 2021 | -7.70 Mn |
API Access
Forte Biosciences EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=FBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "FBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=FBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();